Sunday, November 17, 2024
- 10:30AM-12:30PM
-
Abstract Number: 1466
Apremilast Treatment in Early Oligoarticular Psoriatic Arthritis Improves Clinical and Patient-Reported Outcomes for up to 48 Weeks – Data from a Phase 4 Trial
SpA Including PsA – Treatment Poster II- 10:30AM-12:30PM
-
Abstract Number: 1612
Arterial Involvement Distribution on 18FFDG PET-CT in Giant Cell Arteritis: Variances Based on Clinical Phenotype
Vasculitis – Non-ANCA-Associated & Related Disorders Poster II- 10:30AM-12:30PM
-
Abstract Number: 1633
Arthritis Activity Significantly Affects Quality of Life in Behcet’s Disease Patients
Vasculitis – Non-ANCA-Associated & Related Disorders Poster II- 10:30AM-12:30PM
-
Abstract Number: 1304
Assessing Knowledge and Aptitude in Antinuclear Antibody Testing Among Internal Medicine Residents
Professional Education Poster- 10:30AM-12:30PM
-
Abstract Number: 1263
Assessing Lupus Low Disease Activity State in the Pediatric Rheumatology Clinic: Baseline Data Collection from a Pediatric Lupus Collaborative
Pediatric Rheumatology – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1182
Assessing Male Pelvic Floor Contractions Using a Novel External Pressure Device and Ultrasound
Orthopedics, Low Back Pain, & Rehabilitation – ACR/ARP Poster- 10:30AM-12:30PM
-
Abstract Number: 1062
Assessing Musculoskeletal Symptom Burden in a Cohort of Patients with Hidradenitis Suppurativa Using the IDEOM MSK-Q
Measures & Measurement of Healthcare Quality Poster- 10:30AM-12:30PM
-
Abstract Number: 1452
Assessing Responsiveness of Outcome Measures for Children with Axial Juvenile Spondyloarthritis (JSpA)
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1513
Assessing Subjective Cognitive Impairment in a Cohort of Canadian Systemic Lupus Erythematosus Patients: Construct Validity of PDQ-20
SLE – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1334
Assessing the Performance of Validated Frailty Instruments in Veterans with Rheumatoid Arthritis (RA)
RA – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1076
Assessing the Reliability of ChatGPT on Recombinant Zoster Vaccination for Patients with Rheumatic and Musculoskeletal Diseases
Measures & Measurement of Healthcare Quality Poster- 10:30AM-12:30PM
-
Abstract Number: 1301
Assessment and Comparison of Long-term Skill Retention Following a Teledidactic Musculoskeletal Ultrasound Course for Medical Students– the TELMUS Follow-up Study
Professional Education Poster- 10:30AM-12:30PM
-
Abstract Number: 0976
Assessment of Current Trends in Demographic and Clinical Characteristics of Male Patients with Rheumatoid Arthritis in North India